Parvo Shield (Canada)

This page contains information on Parvo Shield for veterinary use.
The information provided typically includes the following:

Parvo Shield Indications
Warnings and cautions for Parvo Shield
Direction and dosage information for Parvo Shield

Parvo Shield

This treatment applies to the following species:

Swine

Manufacturer: Novartis

Parvovirus Vaccine

Killed Virus

For Use In Animals Only

Parvo Shield Indications

For use in healthy swine as an aid in the prevention of disease caused by porcine parvovirus.

Adjuvant

Aluminum hydroxide

Directions

Shake well before using. Administer 2 mL intramuscularly or subcutaneously 3-4 weeks prior to breeding. Revaccinate prior to each subsequent breeding. Vaccinate boars annually.

Precautions

Store out of direct sunlight at 2°-7° C (35°-45° F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 21 days prior to slaughter. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.

50 Doses

100 mL

130

Nac No.

12310791

NOVARTIS ANIMAL HEALTH CANADA INC.
2000 ARGENTIA RD., SUITE 400, PLAZA 3, MISSISSAUGA, ON, L5N 1V9

Telephone:		800-387-6325
Order Desk:		800-387-6325
Fax:		905-567-0221
Fax Orders:		800-827-5782
Website:		www.ah.ca.novartis.com
Email:		ah.questions@novartis.com

Every effort has been made to ensure the accuracy of the Parvo Shield information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Printable Version

Email Page